Walleye Capital’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,400
Closed -$18.5K 4951
2025
Q3
$18.5K Sell
2,400
-11,900
-83% -$83.4K ﹤0.01% 4217
2025
Q2
$105K Buy
14,300
+4,100
+40% +$33.1K ﹤0.01% 3754
2025
Q1
$96.8K Sell
10,200
-21,600
-68% -$270K ﹤0.01% 3641
2024
Q4
$524K Buy
31,800
+9,500
+43% +$148K ﹤0.01% 2935
2024
Q3
$329K Buy
+22,300
New +$349K ﹤0.01% 3664
2023
Q2
Sell
-100
Closed -$1.74K 4697
2023
Q1
$1.74K Buy
+100
New +$1.43K ﹤0.01% 3797
2019
Q4
Sell
-35,300
Closed -$675K 2097
2019
Q3
$675K Sell
35,300
-27,500
-44% -$645K 0.04% 609
2019
Q2
$1.38M Buy
+62,800
New +$1.38M 0.15% 178

Other funds holding NEO

Walleye Capital's NEO Position: Q4 2025 in Review

Walleye Capital sold out of NeoGenomics (NEO) in Q4 2025, closing a stake of 3,901 shares — an estimated $30.1K sold.

Walleye Capital first reported a position in NEO in Q2 2019 and held it in 9 quarters. The position peaked at $1.23M in Q1 2022. 256 funds tracked by Wall St. Rank hold NEO as of Q4 2025.

  • Walleye Capital reported no remaining NeoGenomics position as of Q4 2025 after selling out during the quarter.
  • Walleye Capital sold 3,901 NeoGenomics shares in Q4 2025, an estimated $30.1K.
  • Walleye Capital first reported a position in NeoGenomics in Q2 2019 and held it in 9 quarters.
  • Walleye Capital's NeoGenomics position peaked at $1.23M in Q1 2022.
  • 256 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2025.

Based on Walleye Capital's 13F filing for Q4 2025, filed 13 Feb 2026.